Works matching IS 15547914 AND DT 2017 AND VI 13 AND IP 12
Results: 21
Update on Functional Heartburn.
- Published in:
- Gastroenterology & Hepatology, 2017, v. 13, n. 12, p. 725
- By:
- Publication type:
- Article
Highlights in Hepatitis C Virus From the 2017 AASLD Liver Meeting: Commentary.
- Published in:
- Gastroenterology & Hepatology, 2017, v. 13, n. 12, p. 21
- By:
- Publication type:
- Article
100% SVR With 8 Weeks of Ledipasvir/Sofosbuvir in HIV-Infected Men With Acute HCV Infection: Results From the SWIFT-C Trial (Sofosbuvir-Containing Regimens Without Interferon for Treatment of Acute HCV in HIV-1--Infected Individuals).
- Published in:
- Gastroenterology & Hepatology, 2017, v. 13, n. 12, p. 18
- Publication type:
- Article
The C-BREEZE 1 and 2 Studies: Efficacy and Safety of Ruzasvir Plus Uprifosbuvir for 12 Weeks in Adults With Chronic Hepatitis C Virus Genotype 1, 2, 3, 4, or 6 Infection.
- Published in:
- Gastroenterology & Hepatology, 2017, v. 13, n. 12, p. 16
- Publication type:
- Article
Adherence to Pangenotypic Glecaprevir/Pibrentasvir Treatment and SVR12 in HCV-Infected Patients: An Integrated Analysis of the Phase 2/3 Clinical Trial Program.
- Published in:
- Gastroenterology & Hepatology, 2017, v. 13, n. 12, p. 14
- Publication type:
- Article
SOF/VEL/VOX for 12 Weeks in NS5A-Inhibitor--Experienced HCV-Infected Patients: Results of the Deferred Treatment Group in the Phase 3 POLARIS-1 Study.
- Published in:
- Gastroenterology & Hepatology, 2017, v. 13, n. 12, p. 12
- Publication type:
- Article
Efficacy and Safety of Glecaprevir/Pibrentasvir for 8 or 12 Weeks in Treatment-Naive Patients With Chronic HCV Genotype 3: An Integrated Phase 2/3 Analysis.
- Published in:
- Gastroenterology & Hepatology, 2017, v. 13, n. 12, p. 10
- Publication type:
- Article
Hepatitis C Virus Reinfection and Injecting Risk Behavior Following Elbasvir/Grazoprevir Treatment in Participants on Opiate Agonist Therapy: Co-STAR Part B.
- Published in:
- Gastroenterology & Hepatology, 2017, v. 13, n. 12, p. 8
- Publication type:
- Article
Efficacy, Safety, and Pharmacokinetics of Glecaprevir/Pibrentasvir in Adults With Chronic Genotype 1-6 Hepatitis C Virus Infection and Compensated Cirrhosis: An Integrated Analysis.
- Published in:
- Gastroenterology & Hepatology, 2017, v. 13, n. 12, p. 6
- Publication type:
- Article
Highlights in Biosimilars From the World Congress of Gastroenterology at ACG 2017: Commentary.
- Published in:
- Gastroenterology & Hepatology, 2017, v. 13, n. 12, p. 17
- By:
- Publication type:
- Article
FDA Public Forum on Biosimilars.
- Published in:
- Gastroenterology & Hepatology, 2017, v. 13, n. 12, p. 15
- Publication type:
- Article
Patient Perceptions Regarding the Use of Biosimilars in Inflammatory Bowel Disease.
- Published in:
- Gastroenterology & Hepatology, 2017, v. 13, n. 12, p. 12
- Publication type:
- Article
Long-Term Efficacy, Safety, and Immunogenicity Data From a Phase III Confirmatory Study Comparing GP2017, a Proposed Biosimilar, With Reference Adalimumab.
- Published in:
- Gastroenterology & Hepatology, 2017, v. 13, n. 12, p. 11
- Publication type:
- Article
Efficacy of Infliximab Biosimilar for Induction and Maintenance Therapy in Inflammatory Bowel Disease After Switch From Drug Originator: A Meta-Analysis.
- Published in:
- Gastroenterology & Hepatology, 2017, v. 13, n. 12, p. 10
- Publication type:
- Article
Infliximab Assay Used in Clinical Practice Validated for Measuring SB2 Infliximab Biosimilar's Serum Drug and Anti-Drug Antibody Levels.
- Published in:
- Gastroenterology & Hepatology, 2017, v. 13, n. 12, p. 8
- Publication type:
- Article
Biosimilars: What Are They and How Will They Change the Way We Practice?
- Published in:
- Gastroenterology & Hepatology, 2017, v. 13, n. 12, p. 6
- Publication type:
- Article
Highlights in Biosimilars From the World Congress of Gastroenterology at ACG 2017: Introduction.
- Published in:
- Gastroenterology & Hepatology, 2017, v. 13, n. 12, p. 4
- By:
- Publication type:
- Article
Vaccination and Health Maintenance Issues to Consider in Patients With Inflammatory Bowel Disease.
- Published in:
- Gastroenterology & Hepatology, 2017, v. 13, n. 12, p. 717
- By:
- Publication type:
- Article
Benefits, Concerns, and Future Directions of Biosimilars in Inflammatory Bowel Disease.
- Published in:
- Gastroenterology & Hepatology, 2017, v. 13, n. 12, p. 745
- By:
- Publication type:
- Article
Overview of the Updated AASLD Guidelines for the Management of HCC.
- Published in:
- Gastroenterology & Hepatology, 2017, v. 13, n. 12, p. 751
- By:
- Publication type:
- Article
Intragastric Balloons for Obesity Management.
- Published in:
- Gastroenterology & Hepatology, 2017, v. 13, n. 12, p. 737
- By:
- Publication type:
- Article